A population-based case–control teratologic study of promethazine use during pregnancy
Authors:
- Judit KocsisJKJudit Kocsis
- Erzsébet H. PuhóEPErzsébet H. Puhó
- Andrew E. CzeizelACAndrew E. Czeizel
- 1 February 2008
- journal article
- Published by Elsevier in Reproductive Toxicology
- Vol. 25 (2) , 276-285
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Validation studies of drug exposures in pregnant womenPharmacoepidemiology and Drug Safety, 2003
- Description and mission evaluation of the Hungarian case‐control surveillance of congenital abnormalities, 1980–1996Teratology, 2001
- First 25 years of the Hungarian congenital abnormality registryTeratology, 1997
- What proportion of congenital abnormalities can be prevented?BMJ, 1993
- Evaluation of drug intake during pregnancy in the Hungarian case‐control surveillance of congenital anomaliesTeratology, 1990
- A new approach to germinal mutation surveillance: pair-wise evaluation of component elements in unidentified multiple congenital abnormalitiesMutation Research/Reviews in Genetic Toxicology, 1990
- H1-receptor antagonists: Comparative pharmacology and clinical useJournal of Molecular Medicine, 1982
- Drugs and the EmbryoBMJ, 1964
- The effects of drugs used in labor on the fetus and newbornClinical Pharmacology & Therapeutics, 1963
- USE OF PROMETHAZINE (PHENERGAN) HYDROCHLORIDE IN OBSTETRICSJAMA, 1958